White Paper

Mycoplasma Detection in Biopharmaceuticals

Format: PDF file | Document type: White Paper | Promoted Content

This content is provided by SGS Life Science Services, and any views and opinions expressed do not necessarily reflect those of www.biopharma-reporter.com

SGS-LSS-Detection-of-Mycoplasma-in-Biopharmaceuticals-EN-16

The detection of mycoplasma contamination is of utmost concern in bio-therapeutic and vaccine manufacturing. The two pharmacopeia techniques rely on the agar/broth culture test to detect cultivable mycoplasma, along with the indicator cell culture assay. The main drawback with these protocols is that they take 28 days and about one week to complete respectively. This timescale is problematic for products whose shelf-life is short. For this reason, more rapid alternatives are routinely accepted by the regulators, as long as they are well validated.

Related resources from SGS Life Science Services

Supplier info centre